Cost-effectiveness of pharmacist care for managing hypertension in Canada

Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC
Carlo MarraRoss T Tsuyuki

Abstract

More than half of all heart disease and stroke are attributable to hypertension, which is associated with approximately 10% of direct medical costs globally. Clinical trial evidence has demonstrated that the benefits of pharmacist intervention, including education, consultation and/or prescribing, can help to reduce blood pressure; a recent Canadian trial found an 18.3 mmHg reduction in systolic blood pressure associated with pharmacist care and prescribing. The objective of this study was to evaluate the economic impact of such an intervention in a Canadian setting. A Markov cost-effectiveness model was developed to extrapolate potential differences in long-term cardiovascular and renal disease outcomes, using Framingham risk equations and other published risk equations. A range of values for systolic blood pressure reduction was considered (7.6-18.3 mmHg) to reflect the range of potential interventions and available evidence. The model incorporated health outcomes, costs and quality of life to estimate an overall incremental cost-effectiveness ratio. Costs considered included direct medical costs as well as the costs associated with implementing the pharmacist intervention strategy. For a systolic blood pressure reduction of ...Continue Reading

References

Nov 9, 2002·Lancet·Majid EzzatiUNKNOWN Comparative Risk Assessment Collaborating Group
Dec 6, 2003·Hypertension·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Apr 27, 2005·Archives of Internal Medicine·Chi-yuan HsuCarlos Iribarren
Jun 23, 2005·Medical Care·Patrick W SullivanVahram Ghushchyan
Jul 21, 2007·International Journal of Health Care Finance and Economics·Braden J MannsKenneth J Taub
Jan 24, 2008·Circulation·Ralph B D'AgostinoWilliam B Kannel
May 21, 2008·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Frans H H LeenenGeorge Fodor
Oct 9, 2008·The Canadian Journal of Cardiology·Michael H McGillionPeter Coyte
Jun 10, 2009·Circulation·Michael J PencinaRamachandran S Vasan
Oct 9, 2012·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Nicole MittmannMike Sharma
Jun 26, 2013·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Doug CoyleGeorge A Wells
Dec 7, 2013·Journal of the American Society of Hypertension : JASH·George BakrisLuis Ruilope
Apr 12, 2014·Journal of the American Heart Association·Valérie SantschiGilles Paradis
Aug 19, 2014·Lancet·UNKNOWN Blood Pressure Lowering Treatment Trialists' Collaboration
Dec 4, 2014·Lancet·UNKNOWN Blood Pressure Lowering Treatment Trialists' CollaborationB Neal
Jan 30, 2015·The New England Journal of Medicine·Andrew E MoranLee Goldman
Mar 26, 2015·Circulation. Cardiovascular Quality and Outcomes·Barry L CarterThomas Vaughn
Dec 30, 2015·The Canadian Journal of Cardiology·Raj S PadwalUNKNOWN Outcomes Research Task Force of the Canadian Hypertension Education Program
Apr 9, 2016·Journal of the American College of Cardiology·Ross T TsuyukiBrenda R Hemmelgarn

❮ Previous
Next ❯

Citations

Jan 20, 2018·Current Hypertension Reports·Korey A KenneltyBarry L Carter
Jun 26, 2018·Canadian Journal on Aging = La Revue Canadienne Du Vieillissement·Sarah HewkoGreta G Cummings
May 6, 2019·Applied Health Economics and Health Policy·Shelagh M SzaboAndrew J Lloyd
Aug 4, 2018·Canadian Journal of Public Health = Revue Canadienne De Santé Publique·Lu Wang, Sasha Ramroop
Oct 15, 2019·Hypertension·Hiroshi OkadaRoss T Tsuyuki
May 11, 2018·Antimicrobial Resistance and Infection Control·M H F SakeenaAndrew J McLachlan
Jun 15, 2019·Pharmacy : Journal of Pharmacy, Education and Practice·M H F SakeenaAndrew J McLachlan
Apr 9, 2020·Journal of Pharmaceutical Policy and Practice·Sunil ShresthaAnil Khadka
Nov 23, 2017·Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC·Ross T TsuyukiNadia A Khan
Nov 9, 2019·Current Hypertension Reports·Catherine G DeringtonAdam P Bress
May 28, 2019·Journal of Correctional Health Care : the Official Journal of the National Commission on Correctional Health Care·Caitlyn ThomsonPeter Macek
Sep 22, 2018·Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC·Ross T Tsuyuki
May 22, 2019·Leukemia & Lymphoma·Michelle DurandDavid Sanford
Jan 11, 2018·Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC·Sarah A LambRoss T Tsuyuki
Sep 20, 2019·Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC·Nadia KhanRoss T Tsuyuki
Nov 3, 2020·The Journal of International Medical Research·Wei ChengRuigang Hou
Jun 3, 2020·Research in Social & Administrative Pharmacy : RSAP·Dhanya NairCarlo A Marra
Feb 2, 2021·Journal of Pharmaceutical Policy and Practice·Ivona Mostarac, Clare L Atzema
Sep 24, 2020·Journal of the American Pharmacists Association : JAPhA·Candace NecykDean T Eurich
May 5, 2021·BMC Health Services Research·Rakhee RaghunandanAlesha Smith
Jul 17, 2021·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Mark NuijtenAgnieszka Marczewska

❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapy

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.